We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.02B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$944M
3
T icon
AT&T
T
+$753M
4
VXF icon
Vanguard Extended Market ETF
VXF
+$553M
5
LIN icon
Linde
LIN
+$379M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$331M
2
FDC
First Data Corporation
FDC
+$331M
3
GWR
Genesee & Wyoming Inc.
GWR
+$312M
4
BX icon
Blackstone
BX
+$277M
5
FE icon
FirstEnergy
FE
+$261M

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFMS
3951
DELISTED
Conformis, Inc. Common Stock
CFMS
$27K ﹤0.01%
593
+26
+5% +$1.56K
CHAP
3952
DELISTED
Chaparral Energy, Inc.
CHAP
$27K ﹤0.01%
19,658
+1,381
+8% +$3.82K
EYPT icon
3953
EyePoint Inc
EYPT
$1.03B
$26K ﹤0.01%
1,442
+393
+37% +$6.09K
LITS
3954
Lite Strategy Inc
LITS
$32.8M
$26K ﹤0.01%
794
+253
+47% +$9.22K
VATE icon
3955
INNOVATE Corp
VATE
$111M
$25K ﹤0.01%
+1,065
New +$23.1K
XNET
3956
Xunlei
XNET
$340M
$25K ﹤0.01%
11,105
– –
GEN
3957
DELISTED
Genesis Healthcare, Inc.
GEN
$22K ﹤0.01%
19,884
+4,991
+34% +$5.77K
AXAS
3958
DELISTED
Abraxas Petroleum Corp
AXAS
$20K ﹤0.01%
1,998
+197
+11% +$2.79K
KUST
3959
Kustom Entertainment Inc
KUST
$777K
– –
0
– –
SB icon
3960
Safe Bulkers
SB
$795M
$19K ﹤0.01%
11,165
-852
-7% -$1.66K
MRNS
3961
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$18K ﹤0.01%
2,983
+23
+0.8% +$186
MRSN
3962
DELISTED
Mersana Therapeutics
MRSN
$17K ﹤0.01%
+435
New +$31.6K
MBII
3963
DELISTED
Marrone Bio Innovations, Inc.
MBII
$17K ﹤0.01%
12,398
+727
+6% +$1.03K
TYME
3964
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$15K ﹤0.01%
12,282
-10,051
-45% -$12.7K
XELA
3965
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$13K ﹤0.01%
1
– –
VSA
3966
VisionSys AI
VSA
$8.35M
$12K ﹤0.01%
5
– –
VBIV
3967
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$9K ﹤0.01%
673
+241
+56% +$5.05K
ASNA
3968
DELISTED
Ascena Retail Group, Inc.
ASNA
$9K ﹤0.01%
1,808
-9,281
-84% -$69.1K
A icon
3969
CALL
Agilent Technologies
A
$39.1B
– –
-50,000
Closed -$3.73M
A icon
3970
PUT
Agilent Technologies
A
$39.1B
– –
-142,700
Closed -$10.7M
ACRS icon
3971
Aclaris Therapeutics
ACRS
$726M
– –
-51,593
Closed -$113K
ADPT icon
3972
Adaptive Biotechnologies
ADPT
$3.59B
– –
-61,000
Closed -$2.95M
AMCR icon
3973
CALL
Amcor
AMCR
$20.8B
– –
-132,978
Closed -$7.64M
AMCR icon
3974
PUT
Amcor
AMCR
$20.8B
– –
-2,040
Closed -$117K
APH icon
3975
PUT
Amphenol
APH
$198B
– –
-60,000
Closed -$1.44M
157 158
159
160 161

Similar funds

CSIA
Charles Schwab Investment Advisory San Francisco, California $72.8B AUM 10.03% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return
DPAM
Degroof Petercam Asset Management Brussels, Belgium $8.32B AUM
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
CW
Connectus Wealth Cincinnati, Ohio $3.66B AUM 26.47% 1-Year Est. Return

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.